Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
W. Mike Heath ASHP Federal Forum Posters
All Days
Sun, Dec 4
W. Mike Heath ASHP Federal Forum Posters
Type here to filter the list
Sunday, December 4, 2022
3:30 PM – 5:00 PM
(1-266) A Pharmacist’s Impact in the Medication Optimization for Veterans with Heart Failure with a Reduced Ejection Fraction
Favorite
3:30 PM – 5:00 PM
(1-026) A Review of Toxicities for First Line Chemotherapeutic Regimens in Veterans with Metastatic Colorectal Cancer
Favorite
3:30 PM – 5:00 PM
(1-073) Adverse Events Associated with the Concomitant Use of Opioids with Benzodiazepines or Z-Hypnotics
Favorite
3:30 PM – 5:00 PM
(1-342) All Hands-on Deck! Standardizing Substance Use Disorder Care Infrastructure in an Integrated Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-185) Alprazolam Adverse Effect Incidence Compared to Other Benzodiazepines Within Veterans Health Administration
Favorite
3:30 PM – 5:00 PM
(1-118) An Assessment of Dalbavancin in a Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-215) An Evaluation of Left Ventricular Ejection Fraction and Electrocardiogram Monitoring Among Veterans Receiving Select Oncologic Agents
Favorite
3:30 PM – 5:00 PM
(1-014) Analysis of Impact of coronavirus-19 Regulations on Mental Health Trends in an Institutionalized, Older Adult Population
Favorite
3:30 PM – 5:00 PM
(1-176) Analysis of the Decision Support Order Set for Direct Oral Anticoagulants at the Veterans Affairs Southern Nevada Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-020) Antimicrobial Stewardship Patterns in a Remote Arctic Tribal Facility During the COVID-19 Pandemic
Favorite
3:30 PM – 5:00 PM
(1-093) Antipseudomonal Self-Stewardship Time out Program (SSTOP): Pharmacist Initiative to Optimizing Therapy and Patient Outcome
Favorite
3:30 PM – 5:00 PM
(1-244) Apalutamide-Warfarin Interaction: A Case Report
Favorite
3:30 PM – 5:00 PM
(1-313) Appropriate Antibiotic Prescribing for Urinary Tract Infection Among Spinal Cord Injury Veterans
Favorite
3:30 PM – 5:00 PM
(1-172) Appropriate Monitoring for Azathioprine and Mercaptopurine
Favorite
3:30 PM – 5:00 PM
(1-234) Appropriateness of Empiric and De-Escalated Antibiotic Therapy for Community-Acquired Pneumonia and Urinary Tract Infections in an Inpatient Setting
Favorite
3:30 PM – 5:00 PM
(1-267) Are Single Doses of IV/IM Ketorolac and Dexamethasone Given in the ED Safe for Patients 65 Years of Age or Older?
Favorite
3:30 PM – 5:00 PM
(1-023) Assessing Barriers and Identifying Facilitators to Improve Prescriber Referral and Initiation of Pre-exposure Prophylaxis for HIV at a Single Institution in Phoenix, Arizona,
Favorite
3:30 PM – 5:00 PM
(1-078) Assessing Bleeding Risk Mitigation in Patients Receiving Combination Antithrombotic Therapy: A Study on Blood Pressure Control and Prescribing Patterns
Favorite
3:30 PM – 5:00 PM
(1-252) Assessing Change in PEG Scale for Veterans Enrolled in a Pharmacist Managed Chronic Pain Clinic
Favorite
3:30 PM – 5:00 PM
(1-210) Assessing Clostridioides Difficile Infection with Empiric Use of Doxycycline in Community-acquired Pneumonia
Favorite
3:30 PM – 5:00 PM
(1-109) Assessing Insulin Requirements and Weight Change After Addition of Glucagon-like Peptide Receptor Agonists in the Treatment of Veterans with Type 2 Diabetes
Favorite
3:30 PM – 5:00 PM
(1-092) Assessing Prescriber Patterns in Communicating of Problematic Urine Drug Test Results and Pharmacist Interventions for Optimizing Risk Mitigation Strategies
Favorite
3:30 PM – 5:00 PM
(1-261) Assessing the Clinical Impact of Pharmacist Home Visits for Veterans Enrolled in Home-Based Primary Care
Favorite
3:30 PM – 5:00 PM
(1-348) Assessing the Impact of a Central Pharmacist Coordinator and Medication Therapy Management Training on Patient Interventions Across a Midwest Community Pharmacy Chain
Favorite
3:30 PM – 5:00 PM
(1-332) Assessing the Impact of Enhanced Integration of Clinical Pharmacist Practitioners (CPP) in Patient Aligned Care Teams
Favorite
3:30 PM – 5:00 PM
(1-144) Assessing the Implementation of a Pharmacy-Driven Medication Reconciliation upon Admission to a General Medicine Unit in a Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-322) Assessing the Utility of Immunohistochemistry for Detecting Human Epidermal Growth Factor Receptor 2 Expression in Metastatic Prostate Cancer at a Veterans Affairs Hospital
Favorite
3:30 PM – 5:00 PM
(1-341) Assessment and Evaluation of Inappropriate/Overdrawn Urine Cultures
Favorite
3:30 PM – 5:00 PM
(1-119) Assessment of a Naloxone Distribution Plan in a Veteran Population Who Experienced an Opioid-Related Overdose Event
Favorite
3:30 PM – 5:00 PM
(1-139) Assessment of Discontinuation Rates of Empagliflozin Due to Adverse Drug Reactions in Adults 75 Years or Older
Favorite
3:30 PM – 5:00 PM
(1-116) Assessment of Preoperative Diabetes Management for Patients Undergoing Elective Surgeries at a Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-061) Assessment of Sodium Zirconium Cyclosilicate for Acute Treatment of Hyperkalemia at a Veterans Affairs (VA) Hospital
Favorite
3:30 PM – 5:00 PM
(1-125) Assessment of the Current Utilization of Pharmacogenomic Testing Results on Selection And/or Modification of Antidepressant Therapy in a Veterans Affairs Health Care System
Favorite
3:30 PM – 5:00 PM
(1-181) Association of Medication Use and Falls in Geriatric Residents of a VA Community Living Center
Favorite
3:30 PM – 5:00 PM
(1-040) Calculated AUC/MIC Ratio for Vancomycin with a MIC of 1-2 mg/L for All MRSA Isolates Excluding Bacteremia Within a Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-214) Characterization of Acute and Postsurgical Pain Management in Patients Receiving Buprenorphine or Buprenorphine/naloxone
Favorite
3:30 PM – 5:00 PM
(1-292) Characterization of Patient Features and Clinical and Operational Outcomes Associated with Continuous Glucose Monitoring
Favorite
3:30 PM – 5:00 PM
(1-179) Chronic Obstructive Pulmonary Disease Exacerbation Medication Kits for High-Risk Patients Receiving Home-Based Primary Care Within the Sierra Nevada Veteran Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-111) Clinical Impact of Implementation of the Diabetes Distress Score Tool on Type 2 Diabetes Management in VA Outpatient Clinics
Favorite
3:30 PM – 5:00 PM
(1-246) Comparing Low Dose (Microdosing) versus Traditional Dosing of Buprenorphine/Naloxone for Patients with Opioid Use Disorder
Favorite
3:30 PM – 5:00 PM
(1-287) Comparing Outcomes and Toxicities with Standard and Reduced Dose Melphalan in Autologous Stem Cell Rescue Patients with Multiple Myeloma
Favorite
3:30 PM – 5:00 PM
(1-276) Comparison of All-Cause Mortality and Benzodiazepine Related Hospitalizations Between Veterans on a Reduced Benzodiazepine Dose and Veterans Who Successfully Discontinue Use Post Benzodiazepine Tapering
Favorite
3:30 PM – 5:00 PM
(1-274) Comparison of Bleeding Rates Between Rivaroxaban and Apixaban Among NSAID Users versus Non-NSAID Users
Favorite
3:30 PM – 5:00 PM
(1-127) Comparison of Cefazolin versus Ceftriaxone for the Treatment of Methicillin-Susceptible Staphylococcus Aureus Bacteremia Among the Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-346) Comprehensive Medication Management Practice Management Evaluation in the Department of Veterans Affairs
Favorite
3:30 PM – 5:00 PM
(1-321) Consolidated Mail Outpatient Pharmacy Canceled Prescriptions at VA Puget Sound Health Care System
Favorite
3:30 PM – 5:00 PM
(1-064) Continuous Glucose Monitoring Devices and Blood Glucose Control in Veterans with Type 2 Diabetes
Favorite
3:30 PM – 5:00 PM
(1-310) Continuous Glucose Monitoring Impact on Glycated Hemoglobin Test (HbA1c) Trends in Geriatric Patients
Favorite
3:30 PM – 5:00 PM
(1-167) Conversion to AUC/MIC Vancomycin Dosing
Favorite
3:30 PM – 5:00 PM
(1-126) Correlation Between Anticoagulant Treatment Options and Incidence of Venous Thromboembolism in the Setting of Moderate to Severe COVID-19 Infections
Favorite
3:30 PM – 5:00 PM
(1-051) Corticosteroid-induced Mania Following an Intramuscular Methylprednisolone Injection
Favorite
3:30 PM – 5:00 PM
(1-351) Design and Development of a Denosumab Administration Dashboard for Pharmacists Within the Salt Lake City VA Health Care System: A Qualitative Improvement Project
Favorite
3:30 PM – 5:00 PM
(1-137) Design and Implementation of a Teratogenic Medication Monitoring System at a Veteran Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-104) Determining Actionable Veterans for Completion of Pharmacogenomic Testing to Guide Medication Therapy for Post-Traumatic Stress Disorder
Favorite
3:30 PM – 5:00 PM
(1-256) Determining Risk Factors for Pseudomonas Aeruginosa Infection in Adult Veterans Diagnosed with Community-acquired Pneumonia at the VA Caribbean Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-105) Developing an Ambulatory Care Pharmacy Residency Within a Virtual Care Model
Favorite
3:30 PM – 5:00 PM
(1-022) Developing, Implementing, and Assessing an Ambulatory Care Clinic Pharmacist Training Program for a National Clinical Pharmacy Specialist Clinic
Favorite
3:30 PM – 5:00 PM
(1-224) Development and Implementation of an Interdisciplinary Overdose Review Team (ORT) at a Rural Veterans Affairs (VA) Hospital
Favorite
3:30 PM – 5:00 PM
(1-166) Development of an Interdisciplinary Medication Safety Work Group for Inpatient Insulin Management Within Montana VA
Favorite
3:30 PM – 5:00 PM
(1-335) Development of an Opioid Renewal Query for the Management of Opioid Prescriptions for Palliative Care Patients
Favorite
3:30 PM – 5:00 PM
(1-297) Documentation of Naloxone Education in Veterans at a Veterans Affairs Medical Center Who Are Prescribed Naloxone
Favorite
3:30 PM – 5:00 PM
(1-044) Drug Shortages in Saudi Arabia: A Cross-sectional Study
Favorite
3:30 PM – 5:00 PM
(1-024) Effect of a Delirium Protocol on the Use of Deliriogenic Medications in Hospitalized Older Veterans
Favorite
3:30 PM – 5:00 PM
(1-309) Effect of Addition of the Sodium-glucose cotransporter-2 Inhibitor Empagliflozin on Diuretic Dosing in Patients Taking a Loop Diuretic
Favorite
3:30 PM – 5:00 PM
(1-326) Effect of Continuous Glucose Monitoring on A1c Reduction and Hypoglycemia Prevention in a Real-World Veteran Population with Diabetes
Favorite
3:30 PM – 5:00 PM
(1-153) Effect of Direct-to-Consumer (DTC) Education Plus Pharmacist Outreach in the Reduction of Benzodiazepines in Participants with Posttraumatic Stress Disorder
Favorite
3:30 PM – 5:00 PM
(1-264) Effect of Extending Long-Acting Injectable Antipsychotic Dosing Intervals Due to the COVID-19 Pandemic in Persons at the Columbia VAHCS
Favorite
3:30 PM – 5:00 PM
(1-302) Effect of Pregabalin Initiation on Diuretic Requirements in Veterans with Chronic Heart Failure
Favorite
3:30 PM – 5:00 PM
(1-112) Effect of Statins on Cognition in Veterans with Type 2 Diabetes
Favorite
3:30 PM – 5:00 PM
(1-142) Effect of the Home-Based Primary Care Blister Pack Program on Hypertension Outcomes in a Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-213) Effectiveness of a Medication Review Consult on Fall Risk in Older Veterans
Favorite
3:30 PM – 5:00 PM
(1-243) Effectiveness of Implementing a Vancomycin Dosing Competency at a Rural Hospital
Favorite
3:30 PM – 5:00 PM
(1-114) Effectiveness of Pharmacist-driven Thromboprophylaxis Screening Utilizing the Khorana Score
Favorite
3:30 PM – 5:00 PM
(1-156) Effects of Antipsychotic Polypharmacy on Diabetes Mellitus Prevalence and Blood Glucose Control
Favorite
3:30 PM – 5:00 PM
(1-319) Effects of Pharmacist-led CMR on Deprescribing in the Geriatric Primary Care Clinic
Favorite
3:30 PM – 5:00 PM
(1-128) Efficacy and Safety of Oral Antibiotics in Obese versus Non-Obese Veterans for Treatment of Skin and Soft Tissue Infections
Favorite
3:30 PM – 5:00 PM
(1-283) Efficacy and Safety of Semaglutide versus Dulaglutide in a Veterans Affairs Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-146) Efficacy of Switching to Alternate Tumor Necrosis Factor-Alpha Inhibitor in Veterans with Psoriasis or Psoriatic Arthritis Who Experienced Treatment Failure
Favorite
3:30 PM – 5:00 PM
(1-219) Empiric Antibiotic Usage for Neisseria Gonorrhoeae and Chlamydia Trachomatis in the Emergency Department
Favorite
3:30 PM – 5:00 PM
(1-347) Establishing Meaningful VA Ambulatory Care Pharmacy Metrics
Favorite
3:30 PM – 5:00 PM
(1-047) Evaluating a Pharmacist-Led Initiative to Increase Harm Reduction Services Access in a High-Risk Housing Facility for Homeless Veterans
Favorite
3:30 PM – 5:00 PM
(1-198) Evaluating Appropriate Monitoring Parameters in Veterans Taking Amiodarone
Favorite
3:30 PM – 5:00 PM
(1-037) Evaluating Changes in Clinical Outcomes in Veterans Converted from Liraglutide to Semaglutide
Favorite
3:30 PM – 5:00 PM
(1-102) Evaluating Clinical Pharmacy Technicians and Their Impact on Optimizing Clinical Pharmacist Practitioner Roles and Patient Care Within Anticoagulation and Primary Care Aligned Team (PACT) Clinics
Favorite
3:30 PM – 5:00 PM
(1-206) Evaluating Effectiveness of Pharmacy Intervention in Initial Smoking Cessation Counseling in Patients Who Are Current Smokers at Northport Veteran's Affairs Medical Center (VAMC)
Favorite
3:30 PM – 5:00 PM
(1-207) Evaluating Guideline Directed Heart Failure Medication Therapy Prescribing Practices in Recently Hospitalized Patients at Northport Veteran’s Affairs Medical Center (VAMC)
Favorite
3:30 PM – 5:00 PM
(1-091) Evaluating Outcomes Based on Pharmacogenomic Testing for Veterans (PHASER)
Favorite
3:30 PM – 5:00 PM
(1-077) Evaluating Outcomes of the Miami Veteran’s Affairs Healthcare System Syringe Service Program
Favorite
3:30 PM – 5:00 PM
(1-183) Evaluating Provider Perception on the Role of Naloxone Use in Veterans with Stimulant Use Disorder (StimUD)
Favorite
3:30 PM – 5:00 PM
(1-157) Evaluating the Effects of an Ideal Clinical Pharmacy Specialist Ratio on Quality Metrics Within a Veterans Health Administration Health Care System
Favorite
3:30 PM – 5:00 PM
(1-143) Evaluating the Effects of Implementing a Dashboard in Monitoring Direct Oral Anticoagulants in Appropriate Prescribing Patterns
Favorite
3:30 PM – 5:00 PM
(1-245) Evaluating the Impact of Pharmacist-led Prescribing of Pharmacotherapy for Alcohol Use Disorder at a VA Rehabilitation Center
Favorite
3:30 PM – 5:00 PM
(1-320) Evaluating the Implementation of Local VA Puget Sound Health Care System (VAPSHCS) Antimicrobial Prophylaxis Guidelines in Patients Treated for Multiple Myeloma
Favorite
3:30 PM – 5:00 PM
(1-054) Evaluating the Prevalence of Osteopenia or Osteoporosis in Veterans on Long-Term Warfarin Therapy at VA Sierra Nevada Health Care System Anticoagulation Clinic
Favorite
3:30 PM – 5:00 PM
(1-190) Evaluating the Utilization of Omega-3-Fatty Acids at Crownpoint Service Unit
Favorite
3:30 PM – 5:00 PM
(1-229) Evaluating Use of Skeletal Muscle Relaxants in the Outpatient Setting of a Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-160) Evaluation of a National VA Formulary Conversion Between ICS/LABA Inhalers
Favorite
3:30 PM – 5:00 PM
(1-222) Evaluation of a Pharmacist-led Home Blood Pressure Monitoring Program at a Rural Midwestern Indian Health Service Clinic
Favorite
3:30 PM – 5:00 PM
(1-100) Evaluation of Acceptance of Recommendations from the Overdose Review Team
Favorite
3:30 PM – 5:00 PM
(1-311) Evaluation of Adherence to Baseline Screening and Routine Safety Monitoring Parameters for Tumor Necrosis Factor-Alpha (TNF-α) Inhibitors at Salem VA Medical Center
Favorite
3:30 PM – 5:00 PM
(1-087) Evaluation of Adherence to Intravenous Heparin Anticoagulation Protocol: Quality Improvement
Favorite
3:30 PM – 5:00 PM
(1-253) Evaluation of Amiodarone Monitoring in the Primary Care Setting at a Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-056) Evaluation of an Updated Heparin Protocol at Veterans Affairs Central California Health Care System
Favorite
3:30 PM – 5:00 PM
(1-177) Evaluation of Anti-Agitation Medication Prescribing Patterns by Age in the Emergency Department
Favorite
3:30 PM – 5:00 PM
(1-170) Evaluation of Anticoagulation Reversal Management in a Veterans Affairs Health Care System
Favorite
3:30 PM – 5:00 PM
(1-171) Evaluation of Appropriate Treatment and Total Duration of Therapy for Non-purulent and Purulent Cellulitis
Favorite
3:30 PM – 5:00 PM
(1-138) Evaluation of Aspirin Use for Primary Prevention in Veterans Older Than 70 Years Old
Favorite
3:30 PM – 5:00 PM
(1-019) Evaluation of Automatic Dispensing Cabinet (ADC) Utilization at Alaska Native Medical Center
Favorite
3:30 PM – 5:00 PM
(1-145) Evaluation of Bone and Joint Infection Treatment at the Veteran’s Affairs Ann Arbor Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-317) Evaluation of Buprenorphine Low-dose Induction Regimens Used in Inpatient and Outpatient Settings
Favorite
3:30 PM – 5:00 PM
(1-050) Evaluation of Cardiovascular, Renal and Safety Outcomes for Empagliflozin in the VA Central California Health Care System Population
Favorite
3:30 PM – 5:00 PM
(1-059) Evaluation of Continuous Glucose Monitoring Devices in a Home Based Primary Care Setting
Favorite
3:30 PM – 5:00 PM
(1-107) Evaluation of Dalbavancin and Oritavancin Utilization and Cost Comparison to Vancomycin and Daptomycin
Favorite
3:30 PM – 5:00 PM
(1-089) Evaluation of DPP-4i Use and Optimization of Diabetic Regimen Through the Use of a Population Management Tool in a Veteran Population with Heart Failure
Favorite
3:30 PM – 5:00 PM
(1-099) Evaluation of Epoetin Alfa Use in Hemodialysis at the West Palm Beach Veterans Affairs Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-254) Evaluation of Extended Infusion Protocol for Beta Lactam at the Veterans Affairs Caribbean Healthcare System Intensive Care Unit
Favorite
3:30 PM – 5:00 PM
(1-259) Evaluation of Fluticasone/Salmeterol Dry Powder Inhaler versus Budesonide/Formoterol Metered Dose Inhaler in the Management of Chronic Obstructive Pulmonary Disease Among Veterans
Favorite
3:30 PM – 5:00 PM
(1-085) Evaluation of Glucose Control in Patients Receiving Basal Insulin: A Comparative Review
Favorite
3:30 PM – 5:00 PM
(1-306) Evaluation of Glucose Control with a Continuous Glucose Monitor in Veterans with Type II Diabetes
Favorite
3:30 PM – 5:00 PM
(1-035) Evaluation of Gout Management for Patients on Oral Gout Prophylaxis at a Large Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-039) Evaluation of Guideline Directed Therapy for Veterans with Type II Diabetes and Chronic Kidney Disease with Concomitant Albuminuria
Favorite
3:30 PM – 5:00 PM
(1-165) Evaluation of Hypoglycemia Management for Patients with Type 1 or Type 2 Diabetes Mellitus During Hospitalization at a Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-260) Evaluation of Institution Specific Procedures for Confirmatory Testing of Fentanyl Positive Results as a Part of Urine Drug Screens
Favorite
3:30 PM – 5:00 PM
(1-097) Evaluation of Intravenous Iron Use in Veterans with Non-malignant Related Iron Deficiency Anemia
Favorite
3:30 PM – 5:00 PM
(1-273) Evaluation of Ketamine Infusions for Chronic Pain at Tennessee Valley Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-063) Evaluation of Long-Acting Injectable Antipsychotic (LAIA) Prescribing Patterns Throughout the COVID-19 Pandemic at a VA Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-242) Evaluation of Medication Discrepancies During Internal Hospital Transfer Between Medicine or Surgery and Intensive Care Services
Favorite
3:30 PM – 5:00 PM
(1-209) Evaluation of Metabolic Monitoring Adherence for Patients Taking Clozapine, Olanzapine, and Quetiapine
Favorite
3:30 PM – 5:00 PM
(1-012) Evaluation of Metabolic Monitoring in the Elderly After Antipsychotic Initiation in the Outpatient Setting
Favorite
3:30 PM – 5:00 PM
(1-062) Evaluation of Molnupiravir Prescribing for Outpatient COVID-19 Treatment at the VA Connecticut (VACT) Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-121) Evaluation of Patients Post-discharge from the Inpatient Psychiatry Unit at the Iowa City Veterans Affairs Health Care System
Favorite
3:30 PM – 5:00 PM
(1-174) Evaluation of Patients Prescribed Zolpidem for Insomnia Across Veterans Affairs Nebraska-Western Iowa Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-164) Evaluation of Peri-procedural Antibiotic Use for Surgical Site Infection (SSI) Prophylaxis in Patients Undergoing Neurosurgical Procedures and Postoperative Outcomes
Favorite
3:30 PM – 5:00 PM
(1-285) Evaluation of Prescribing Trends for Newly Approved Naloxone HCl Nasal Spray 8mg (Kloxxado™) to Naloxone HCl Nasal Spray 4mg (Narcan®) to Prevent Opioid Overdose
Favorite
3:30 PM – 5:00 PM
(1-238) Evaluation of Pulmonary Artery (PA) Pressure Implanted Remote Monitoring HF System in Patients with Heart Failure
Favorite
3:30 PM – 5:00 PM
(1-298) Evaluation of Risk Factors for Tacrolimus-Induced Hypomagnesemia in Solid Organ Transplant Recipients
Favorite
3:30 PM – 5:00 PM
(1-070) Evaluation of Safety Outcomes Following Conversion of Formulary-Preferred Inhaled Corticosteroid/Long-Acting Beta-2 Agonist Inhalers in a Veterans Affairs Population
Favorite
3:30 PM – 5:00 PM
(1-058) Evaluation of Semaglutide Efficacy in Patients with Type 2 Diabetes Mellitus in a Veterans Affairs Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-055) Evaluation of SSTI Order Set Implementation on Emergency Department Antibiotic Prescribing
Favorite
3:30 PM – 5:00 PM
(1-299) Evaluation of Statin-Associated Muscle Symptoms in Patients Initiated on Statin Therapy While Simultaneously Repleting Vitamin D Levels at a Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-068) Evaluation of Target Prazosin Dosing for Posttraumatic Stress Disorder-related Nightmares
Favorite
3:30 PM – 5:00 PM
(1-318) Evaluation of TCA Prescribing in Geriatric Patients Within VA Puget Sound Health Care System
Favorite
3:30 PM – 5:00 PM
(1-231) Evaluation of Teratogenic Medication Reviews in Female Veterans Who Are Pregnant or Attempting Pregnancy at the Dayton Veterans Affairs (VA) Medical Center
Favorite
3:30 PM – 5:00 PM
(1-053) Evaluation of the Clinical Significance and Impact of Coagulase-Negative Staphylococci in Blood Cultures at a Veterans Affairs Facility
Favorite
3:30 PM – 5:00 PM
(1-096) Evaluation of the Co-administration of as Needed Acetaminophen and Acetaminophen-containing Products for Pain in a Community Living Center Veteran Affairs Population
Favorite
3:30 PM – 5:00 PM
(1-228) Evaluation of the Effect of Glucagon-Like Peptide-1 Analogues in Weight Management and Type 2 Diabetes Mellitus Control
Favorite
3:30 PM – 5:00 PM
(1-007) Evaluation of the Effectiveness of Academic Detailing on Utilization of Pharmacogenomics Testing
Favorite
3:30 PM – 5:00 PM
(1-315) Evaluation of the Prescribing of Nirmatrelvir/Ritonavir at a Tertiary Military Facility: A Medication Use Evaluation
Favorite
3:30 PM – 5:00 PM
(1-074) Evaluation of the Protective Factors of Pre-diabetes Among Underserved Patients: A Retrospective Cohort Study
Favorite
3:30 PM – 5:00 PM
(1-060) Evaluation of the Safety and Efficacy of Trazodone for the Treatment of Insomnia in the Outpatient Setting at a Veterans Affairs (VA) Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-331) Evaluation of the Safety of De-Prescribing Inhaled Corticosteroids in Veterans with Mild-to-Moderate Chronic Obstructive Pulmonary Disease
Favorite
3:30 PM – 5:00 PM
(1-069) Evaluation of the Use of Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibitors in Combination with Diuretics in an Outpatient Veterans Affairs Population
Favorite
3:30 PM – 5:00 PM
(1-225) Evaluation of the Utilization, Safety, and Efficacy of Continuous Glucose Monitor Use at the Cincinnati VA Medical Center
Favorite
3:30 PM – 5:00 PM
(1-178) Evaluation of Transgender Pharmacotherapy at VA Sierra Nevada Health Care System
Favorite
3:30 PM – 5:00 PM
(1-161) Evaluation of Unsuccessful Conversions from Budesonide/Formoterol to Fluticasone/Salmeterol in Veterans at the Kansas City Veterans Affair Medical Center (KCVAMC)
Favorite
3:30 PM – 5:00 PM
(1-262) Evaluation of Vancomycin Duration of Therapy Pre and Post Methicillin-Resistant Staphylococcus Aureus (MRSA) Nasal Swab Protocol Implementation
Favorite
3:30 PM – 5:00 PM
(1-013) Evaluation of Vitamin B12 Monitoring for Patients on Metformin at a Veteran Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-052) Evaluation of Zanubrutinib-Associated Fungal Infection Incidence in the Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-086) Expanding the HIV Care Continuum: Identifying Missed Opportunities for HIV Prevention and Clinic Retention Within the Veteran Population Newly Diagnosed with HIV
Favorite
3:30 PM – 5:00 PM
(1-217) Expansion of a Pharmacist Led Battlefield Acupuncture Clinic in a Veteran Community
Favorite
3:30 PM – 5:00 PM
(1-301) Experience with Fosfomycin in the Treatment of Urinary Tract Infections Caused by Non-Escherichia coli Pathogens
Favorite
3:30 PM – 5:00 PM
(1-349) Exploring the Process of Implementing a Mental Health Pharmacogenomics Program at a US Coast Guard Outpatient Clinic
Favorite
3:30 PM – 5:00 PM
(1-029) Fluid Resuscitation in Septic Patients with and Without Heart Failure at a Veterans Affairs Healthcare Facility
Favorite
3:30 PM – 5:00 PM
(1-159) Hospital Discharge Process Quality Improvement Project
Favorite
3:30 PM – 5:00 PM
(1-098) Identifying and Evaluating Patients with Type 2 Diabetes and Chronic Kidney Disease for Use of Finerenone
Favorite
3:30 PM – 5:00 PM
(1-294) Identifying and Reducing Barriers to Clozapine Use at a Veteran Affairs Outpatient Mental Health Clinic
Favorite
3:30 PM – 5:00 PM
(1-220) Identifying Discrepancies and Standardizing Antiarrhythmic Monitoring
Favorite
3:30 PM – 5:00 PM
(1-296) Identifying Predictors of Adherence to Long-acting Naltrexone Injection Following Discharge from an Acute Inpatient Psychiatric Unit
Favorite
3:30 PM – 5:00 PM
(1-305) Impact of a Multimodal Pain Management Order Set in Total Hip and Knee Arthroplasty
Favorite
3:30 PM – 5:00 PM
(1-237) Impact of a Pharmacist Driven Vancomycin Protocol Using an AUC:MIC Ratio-Based Dosing Strategy in a Rural Native American Population
Favorite
3:30 PM – 5:00 PM
(1-269) Impact of a Pharmacist Run Clinic on Diabetes Management at an Indian Health Service Site
Favorite
3:30 PM – 5:00 PM
(1-016) Impact of a Pharmacist-driven Tardive Dyskinesia Education on Adherence to Recommended Abnormal Involuntary Movement Scale (AIMS) Monitoring
Favorite
3:30 PM – 5:00 PM
(1-041) Impact of a Pharmacist-Led Interprofessional Team on Adverse Outcomes of Opioid Prescribing in High-Risk Patients
Favorite
3:30 PM – 5:00 PM
(1-337) Impact of Advanced Comprehensive Diabetes Care (ACDC) Telehealth Program on Glycemic Control in Veterans with Type 2 Diabetes Mellitus
Favorite
3:30 PM – 5:00 PM
(1-288) Impact of an Outpatient Fluoroquinolone Order Set on Prescribing Rates and Usage: A Preliminary Report
Favorite
3:30 PM – 5:00 PM
(1-009) Impact of an Updated Post Discharge Nursing Note Template on Continuation of Care
Favorite
3:30 PM – 5:00 PM
(1-203) Impact of Antipsychotic Medication Reduction Measures on Prescribing Trends of Psychotropic Medications Among Community Living Center Residents
Favorite
3:30 PM – 5:00 PM
(1-015) Impact of Clinical Dashboard on Frequency of Valproic Acid Lab Monitoring in Psychiatric Outpatients
Favorite
3:30 PM – 5:00 PM
(1-248) Impact of Clinical Pharmacist Management in Patients with Uncontrolled Diabetes Mellitus
Favorite
3:30 PM – 5:00 PM
(1-042) Impact of Clinical Pharmacy Interventions to Improve Guideline-Directed Therapy in Patients with a Hemoglobin A1C Greater Than 9 Percent
Favorite
3:30 PM – 5:00 PM
(1-200) Impact of Direct-Acting Antiviral Agents on Metabolic Dysfunction in Veterans with Hepatitis C Virus
Favorite
3:30 PM – 5:00 PM
(1-067) Impact of Dolutegravir versus Bictegravir on Metabolic and Renal Outcomes
Favorite
3:30 PM – 5:00 PM
(1-134) Impact of Hemoglobin A1c on Risk of Developing Urinary Tract and Genitourinary Infections Among Veterans Taking Sodium-glucose cotransporter-2 Inhibitors
Favorite
3:30 PM – 5:00 PM
(1-080) Impact of Infectious Disease Electronic Consultation on Staphylococcus aureus Bacteremia Outcomes and Management
Favorite
3:30 PM – 5:00 PM
(1-136) Impact of Pharmacist Driven Interventions on HIV Pre-Exposure Prophylaxis Initiation, Retention and Laboratory Compliance
Favorite
3:30 PM – 5:00 PM
(1-205) Impact of Pharmacist Intervention on Comprehensive Diabetes Management
Favorite
3:30 PM – 5:00 PM
(1-154) Impact of Pharmacist Intervention on Vaccine Use Among Veterans with Inflammatory Bowel Disease (IBD) at the Minneapolis Veterans Affairs Health Care System (MVAHCS)
Favorite
3:30 PM – 5:00 PM
(1-168) Impact of Pharmacist Interventions in the Management of Prediabetes
Favorite
3:30 PM – 5:00 PM
(1-033) Impact of Pharmacist Involvement in Hepatitis C Screening in a Native American Population in Rural Arizona
Favorite
3:30 PM – 5:00 PM
(1-336) Impact of Pharmacist-Driven Women’s Health Population Management Efforts Within Primary Care Clinics Among a Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-240) Impact of Pharmacist-led Care on Type 2 Diabetes Mellitus Management Outcomes in a Rural Area
Favorite
3:30 PM – 5:00 PM
(1-028) Impact of Pharmacists on Uptake of SGLT2i Prescribing for HFrEF
Favorite
3:30 PM – 5:00 PM
(1-084) Impact of Pharmacogenomic Testing on Citalopram and Escitalopram Prescribing in Veterans
Favorite
3:30 PM – 5:00 PM
(1-008) Impact of Population Management Utilization on Heart Failure Outcomes in a High-Risk Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-189) Impact of Provider Education on Prescribing of Anticholinergic Antidepressants in Older Adults at a Veterans Affairs (VA) Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-280) Impact of Race and Weight on Heart Failure Admissions in Veterans on Sacubitril/Valsartan
Favorite
3:30 PM – 5:00 PM
(1-193) Impact of Semaglutide And/or Empagliflozin on Hemoglobin A1c in the American Indian/Alaskan Native Population
Favorite
3:30 PM – 5:00 PM
(1-281) Impact of Stewardship Intervention on Antibiotic Prescribing Prior to Dental Procedures in a Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-204) Impact of Telemedicine on Glycemic Control in Patients with Type 2 Diabetes Mellitus (T2DM)
Favorite
3:30 PM – 5:00 PM
(1-307) Impact of the Implementation of Provider Education in Reducing Flagged Orders with the West Texas Veterans Affairs Health Care System
Favorite
3:30 PM – 5:00 PM
(1-270) Implementation and Evaluation of a Chronic Headache Clinic at VA Black Hills Health Care System
Favorite
3:30 PM – 5:00 PM
(1-151) Implementation and Impact of a Pharmacist-Led Ambulatory Care Asthma Clinic
Favorite
3:30 PM – 5:00 PM
(1-186) Implementation of a Beta-Lactam Allergy Assessment and Amoxicillin Direct Provocation Test
Favorite
3:30 PM – 5:00 PM
(1-350) Implementation of a Centralized Specialty Medication Management Service at the Madison VA
Favorite
3:30 PM – 5:00 PM
(1-236) Implementation of a Medication Assisted Treatment Program in a Pharmacist Managed Ambulatory Clinic
Favorite
3:30 PM – 5:00 PM
(1-173) Implementation of a Pharmacist Managed Specialty Endocrine Satellite Clinic in a Veterans Affairs Ambulatory Care Clinic
Favorite
3:30 PM – 5:00 PM
(1-131) Implementation of a Pharmacist-led Penicillin Allergy Interview at a Veteran’s Care Facility
Favorite
3:30 PM – 5:00 PM
(1-268) Implementation of a Pharmacist-Monitored Dashboard for Discrepant Urine Drug Screens
Favorite
3:30 PM – 5:00 PM
(1-239) Implementation of a Standardized Conversion Process from Insulin Detemir 100 Units/ml or Insulin Glargine 100 Units/ml to Insulin Glargine 300 Units/ml
Favorite
3:30 PM – 5:00 PM
(1-184) Implementation of Alcohol Use Disorder (AUD) Interventions in the Patient Aligned Care Team (PACT) Pharmacy Setting
Favorite
3:30 PM – 5:00 PM
(1-182) Implementation of an Absolute Risk Assessment Osteoporosis Screening Tool for Male Veterans at VA Sierra Nevada Health Care System
Favorite
3:30 PM – 5:00 PM
(1-345) Implementation of Clinical Pharmacy Services for Initiating SGLT-2 Inhibitors in Hfref Patients on Guideline Directed Medical Therapy
Favorite
3:30 PM – 5:00 PM
(1-188) Implementation of High Dose Naloxone: Guidance for Providers on When to Use Regular versus High Dose Naloxone in the Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-223) Implementation of Lesbian, Gay, Bisexual, Transgender, and Questioning (LGBTQ+) Pharmacy Services at a Rural Veterans Affairs Hospital
Favorite
3:30 PM – 5:00 PM
(1-094) Implementation of Pharmacist-Initiated Proton Pump Inhibitor (PPI) Deprescribing for Ambulatory Care Patients in a Veterans Affairs Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-046) Implementation of Pharmacist-Led Congestive Heart Failure Discharge Education
Favorite
3:30 PM – 5:00 PM
(1-216) Implementation of Pharmacist-Led Levothyroxine Monitoring and Management in a Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-122) Implementation of Pharmacist-led Osteoporosis Screening and Management in a Women’s Health Patient Aligned Care Team (WH-PACT)
Favorite
3:30 PM – 5:00 PM
(1-324) Implementation of Standard Operating Procedures for Radiology Order Review
Favorite
3:30 PM – 5:00 PM
(1-241) Implementation of the CIWA-Ar Protocol (I-CArP) at the Oklahoma City Veterans Health Care System (OKCVAHCS) – a Quality Improvement Project
Favorite
3:30 PM – 5:00 PM
(1-021) Implementation of the Healthy Lifestyles Initiative for Weight Loss Management Within the Nuka System of Care
Favorite
3:30 PM – 5:00 PM
(1-282) Implementation of the Hypoglycemia Safety/Choose Wisely (National VA Initiative) in Patient Aligned Care Team
Favorite
3:30 PM – 5:00 PM
(1-323) Implementation of the Veterans Affairs National Hypoglycemia Safety Initiative Dashboard in a Primary Care Setting at the Washington DC Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-291) Implementation Rates of Pharmacist Recommended De-Escalation of Inhaled Corticosteroids Initiated by COPD Academic Detailing Dashboard
Favorite
3:30 PM – 5:00 PM
(1-194) Implementing 2019 Global Initiative for Asthma Guideline Directed Prescribing at the Crownpoint Service Unit in the Navajo Nation
Favorite
3:30 PM – 5:00 PM
(1-330) Implementing a Revision in Anticoagulation Consult for Patients on Warfarin Being Discharged
Favorite
3:30 PM – 5:00 PM
(1-191) Implementing Hyperlipidemia and Hypertension Management into a Pharmacist-Led Diabetes Management Clinic
Favorite
3:30 PM – 5:00 PM
(1-048) Implementing Naloxone Kit Distribution in a Veterans Affairs Hospital Emergency Department
Favorite
3:30 PM – 5:00 PM
(1-233) Implementing Process Improvement for Offering Naloxone to Veterans Identified at Risk of Opioid Overdose Within Pharmacist-led Clinics
Favorite
3:30 PM – 5:00 PM
(1-247) Implementing the Distribution of Naloxone to Veterans with Stimulant Use Disorder in a Rural Outpatient Veterans Health Administration (VHA) Setting
Favorite
3:30 PM – 5:00 PM
(1-251) Implications of Clozapine Monitoring During the COVID-19 Pandemic
Favorite
3:30 PM – 5:00 PM
(1-011) Improving Access to HIV PrEP Therapies Through Clinical Pharmacist Specialists’ Intervention
Favorite
3:30 PM – 5:00 PM
(1-211) Improving Asthma and Chronic Obstructive Pulmonary Disease Outcomes Through Pharmacist Intervention in a Rural Emergency Care Setting
Favorite
3:30 PM – 5:00 PM
(1-163) Improving Clinical Outcomes for Veterans with Identified Health Inequities Through Clinical Pharmacist Practitioner Comprehensive Care
Favorite
3:30 PM – 5:00 PM
(1-295) Improving Low Complexity Mental Health Services Among Primary Care Providers in an Outpatient Veterans Affairs Clinic
Favorite
3:30 PM – 5:00 PM
(1-316) Improving Semaglutide Weight Documentation After Implementing Formulary Criteria for Use Renewal and Provider Education
Favorite
3:30 PM – 5:00 PM
(1-304) Incidence of Venous Thromboembolism Among Commonly Prescribed Second Generation Antipsychotics
Favorite
3:30 PM – 5:00 PM
(1-043) Increasing Implementation of Guideline Directed Medical Therapy for Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure Patients with Reduced Ejection Fraction
Favorite
3:30 PM – 5:00 PM
(1-133) Initiation of a Harm Reduction Quality Improvement Project Through the Implementation of a Syringe Service Program at the Veterans Affairs Maine Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-250) Inpatient Buprenorphine Inductions via Micro-Dosing Medication-Use Evaluation
Favorite
3:30 PM – 5:00 PM
(1-103) Institutional Protocol for Hospitalized Adult Patients with Reported Beta-lactam Allergy
Favorite
3:30 PM – 5:00 PM
(1-155) Integrating Opioid Use Disorder (OUD) Treatment into Primary Care
Favorite
3:30 PM – 5:00 PM
(1-327) Knowledge and Stigma of Syringe Service Programs: A Survey of Clinicians and Ancillary Workers at a Level 1c Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-329) LEAN Process Improvement Implementation- Minimizing High Risk Medications in Patients with Heart Failure
Favorite
3:30 PM – 5:00 PM
(1-158) Long-Acting Injectable vs Oral Antipsychotics: A Retrospective Review of Efficacy and Cost Effectiveness
Favorite
3:30 PM – 5:00 PM
(1-115) Long-Term Assessment of Weight Loss Medications in a Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-196) Make Rheum for Biosimilars
Favorite
3:30 PM – 5:00 PM
(1-175) Management of the VA Nebraska-Western Iowa Health Care System Lithium Dashboard by Pharmacy Technicians
Favorite
3:30 PM – 5:00 PM
(1-140) Matching the Tool to the Task: Impact of a Geriatrics-tailored Technology Guide on Virtual Visits with Older Adults
Favorite
3:30 PM – 5:00 PM
(1-108) Medication Use Evaluation of Buprenorphine for Chronic Pain in Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-010) Medication Use Evaluation of Sacubitril/Valsartan in a Veterans Affairs Health Care System
Favorite
3:30 PM – 5:00 PM
(1-095) Minimizing the Use of High-risk Medications in Veterans with Heart Failure: A Pharmacy-Led Quality Improvement Project
Favorite
3:30 PM – 5:00 PM
(1-065) Multi-Factorial Analysis of Gastrointestinal Bleeding Risk and Events in Veteran Patients on Combination Antiplatelet-Anticoagulant Therapy
Favorite
3:30 PM – 5:00 PM
(1-300) National Veterans Affairs Hypoglycemic Safety Initiative Implementation at a Community Based Outpatient Clinic
Favorite
3:30 PM – 5:00 PM
(1-278) Optimal Weight-Based Dosing of Vancomycin to Achieve an Area Under the Curve (AUC) of 400-600 Stratified by Body Mass Index (BMI)
Favorite
3:30 PM – 5:00 PM
(1-088) Optimization of a Sexual Health Reminder to Promote Pre-Exposure Prophylaxis Education and Consultation Within the Orlando Veterans Affair Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-340) Optimization of Guideline Directed Pharmacotherapy for the Treatment of Insomnia at a Veterans Affairs Healthcare System: A Quality Improvement Project
Favorite
3:30 PM – 5:00 PM
(1-101) Optimizing Surveillance of Patients with Cirrhosis in a Department of Veterans Affairs Health System
Favorite
3:30 PM – 5:00 PM
(1-045) Optimizing the Inpatient Total Parental Nutrition Process for Inpatient Ordering Process
Favorite
3:30 PM – 5:00 PM
(1-232) Optimizing the Storage and Utilization of Long-Acting Injectable Antipsychotics Within the VA Central Ohio Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-079) Optimizing Women’s Health Teratogenic Medication Monitoring
Favorite
3:30 PM – 5:00 PM
(1-152) Oral Beta-Lactams for Lower Extremity Osteomyelitis at the Minneapolis Veterans Affairs Health Care System
Favorite
3:30 PM – 5:00 PM
(1-289) Outcomes Associated with Single Anti-Platelet Therapy Combined with an Anticoagulant in Patients Undergoing Percutaneous Coronary Intervention with Pre-Existing or New-Onset Atrial Fibrillation
Favorite
3:30 PM – 5:00 PM
(1-271) Outcomes of an Inhaled Corticosteroid De-escalation Initiative Among Outpatient Veterans with Chronic Obstructive Pulmonary Disease
Favorite
3:30 PM – 5:00 PM
(1-227) Outpatient Labels and Paper Management Process Improvement Project Prior to Implementation of Cerner
Favorite
3:30 PM – 5:00 PM
(1-328) Patient Education on Self-Administered Injectable Agents: Retrospective Review of Current Process
Favorite
3:30 PM – 5:00 PM
(1-308) Pharmacist Optimization of Guideline-Directed Medication Therapy (GDMT) in Heart Failure
Favorite
3:30 PM – 5:00 PM
(1-017) Pharmacist-Driven Identification and De-escalation of Unnecessary Aspirin Therapy in Elderly Adults on Concomitant Direct Oral Anticoagulants
Favorite
3:30 PM – 5:00 PM
(1-106) Pharmacist-led Continuous Glucose Monitor Management: Time Spent and Impact on Patient Care
Favorite
3:30 PM – 5:00 PM
(1-344) Pharmacist-led Deprescribing in Polypharmacy Patients at a Rural Veterans Affairs Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-286) Pharmacist-Led Initiative to Improve Glycemic Control Therapies in Veterans
Favorite
3:30 PM – 5:00 PM
(1-272) Pharmacist-Led Initiative to Increase Guideline-Directed Medical Therapies (GDMT) in Veterans with Peripheral Arterial Disease (PAD)
Favorite
3:30 PM – 5:00 PM
(1-090) Pharmacist-Led Interventions to Optimize Diabetes Management in Adults with HbA1c Levels Above 9%
Favorite
3:30 PM – 5:00 PM
(1-339) Pharmacist-Managed Inhaled Corticosteroid De-escalation in Patients with Stable COPD at a Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-117) Pharmacoeconomic Analysis of One-time Intravenous Antibiotic Doses in the Emergency Department
Favorite
3:30 PM – 5:00 PM
(1-162) PHASER Impact on Statin Prescribing
Favorite
3:30 PM – 5:00 PM
(1-034) Population Health Management: Assessing Uptake of Evidence-based Therapies for Heart Failure in a Rural Community
Favorite
3:30 PM – 5:00 PM
(1-005) Prescribing Potentially Unsafe or Unnecessary Medications Prior to Death in Older Veterans with Advanced Life-Limiting Conditions
Favorite
3:30 PM – 5:00 PM
(1-124) Prescribing, Supplementation, and Monitoring of Oral Bisphosphonates for the Treatment of Osteoporosis in Veteran Patients: A Retrospective Study
Favorite
3:30 PM – 5:00 PM
(1-333) Primary Care Provider Perceptions of Osteoporosis Treatment and Fidelity to National Osteoporosis Treatment Guidelines at the William S. Middleton Memorial Veterans Hospital
Favorite
3:30 PM – 5:00 PM
(1-113) Quality Improvements to the Veterans Health Administration’s (VHA) First Syringe Service Program (SSP)
Favorite
3:30 PM – 5:00 PM
(1-032) Rate of Emergency Department Encounters for Treatment-Emergent Anxiety Due to Initiation of High-Dose versus Low-Dose Sertraline
Favorite
3:30 PM – 5:00 PM
(1-031) Real-world Use of anti-SARS-CoV-2 Monoclonal Antibody Therapies for the Treatment of Mild-to-moderate COVID-19
Favorite
3:30 PM – 5:00 PM
(1-075) Reducing Anticholinergic Burden in Veterans 65 Years and Older Taking Multiple Anticholinergic Medications
Favorite
3:30 PM – 5:00 PM
(1-150) Reducing Delay of Elective Surgery via Intensive Preoperative Diabetes Management with Assistance of Personal Continuous Glucose Monitors, an Exploratory Study
Favorite
3:30 PM – 5:00 PM
(1-130) Reduction of Anticholinergic Burden in Veterans with Dementia Through Pharmacist-Driven Deprescribing
Favorite
3:30 PM – 5:00 PM
(1-018) Relapse Rates in Veterans on Buprenorphine/naloxone vs Buprenorphine: A Retrospective Review
Favorite
3:30 PM – 5:00 PM
(1-201) Resistant Hypertension Prescribing Patterns at a Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-195) Rethinking Omeprazole Prescribing Through Medical Staff Education and Technological Interventions at an Urban American Indian/ Alaskan Native Ambulatory Clinic
Favorite
3:30 PM – 5:00 PM
(1-325) Retrospective Analysis of Prescribing Trends of High Volume Providers to Increase Antimicrobial Stewardship Principles at a VA Health System
Favorite
3:30 PM – 5:00 PM
(1-030) Retrospective Chart Review on the Efficacy of Data-Based Opioid Risk Review in Patients with Chronic Pain
Favorite
3:30 PM – 5:00 PM
(1-197) Retrospective Review of Linezolid and Tedizolid Prescribing with Serotonergic Antidepressant Medications and Associated Outcomes Within the Stratton VA Medical Center
Favorite
3:30 PM – 5:00 PM
(1-199) Retrospective Review of Naloxone Prescribing and Risk Stratification in Patients Who Have Received Opioids at Discharge
Favorite
3:30 PM – 5:00 PM
(1-208) Retrospective Review of Naloxone Prescribing and Risk Stratification in Patients Who Have Received Opioids Following Same Day Surgery
Favorite
3:30 PM – 5:00 PM
(1-027) Retrospective Review of Rasburicase in a Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-123) Review and Expansion of the Utilization of a Deprescribing Tool for Home Based Primary Care Medication Reviews
Favorite
3:30 PM – 5:00 PM
(1-230) Review of Outpatient Provider Opioid and Benzodiazepine Co-Prescribing Patterns at a Large Healthcare Facility
Favorite
3:30 PM – 5:00 PM
(1-071) Review of Preventable Adverse Drug Reactions (ADRs) to Identify Trends
Favorite
3:30 PM – 5:00 PM
(1-202) Risk Factors for Discordance Between Methicillin-Resistant Staphylococcus Aureus (MRSA) Nares Screening and Subsequent Clinical Cultures
Favorite
3:30 PM – 5:00 PM
(1-277) Risk of Acute Kidney Injury After Addition of Empagliflozin and Dosing Changes to Background Congestive Heart Failure Therapy in a Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-082) Risk of Hypertriglyceridemia Associated with Diabetes Mellitus and Hyperglycemia in Critically Ill Patients Receiving Propofol
Favorite
3:30 PM – 5:00 PM
(1-025) Safety and Efficacy of First-Line Therapy for Advanced/Metastatic Lung Cancer in Veterans
Favorite
3:30 PM – 5:00 PM
(1-226) Safety Evaluation of Beta Lactam Antibiotics Administered Intravenous Push at Cincinnati Veterans Affairs Medical Center
Favorite
3:30 PM – 5:00 PM
(1-249) Safety Evaluation of Low Dose Rivaroxaban Plus Clopidogrel for Treatment of Peripheral Arterial Disease at Corporal Michael J. Crescenz VA Medical Center
Favorite
3:30 PM – 5:00 PM
(1-129) Safety of Venous Thromboembolism Prophylaxis in Underweight Hospitalized Veteran Patients
Favorite
3:30 PM – 5:00 PM
(1-083) Seven-day vs Fourteen-day Treatment Regimens in Uncomplicated Cases of Gram-negative Rod Bacteremia
Favorite
3:30 PM – 5:00 PM
(1-279) Significance of the Loading Phase Duration of Apixaban on Bleeding Events in Patients Treated for Newly Diagnosed Venous Thromboembolism After Initial Parenteral Anticoagulation Treatment
Favorite
3:30 PM – 5:00 PM
(1-180) Single Center Diabetic Ketoacidosis Protocol Implementation Outcomes versus Individual Prescriber Treatment Approach at the VA of Southern Nevada Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-312) Single Center Retrospective Evaluation of Leuprolide Use in Female Veterans with Endometriosis
Favorite
3:30 PM – 5:00 PM
(1-334) Single Site Evaluation of Clinical Pharmacist Practitioner Impact on Pharmacogenomic-Informed Medication Management in Hematology and Oncology Through the PHASER Program
Favorite
3:30 PM – 5:00 PM
(1-218) Sodium-Glucose Cotransporter-2 Inhibitor Therapy in Veterans with Heart Failure with Reduced Ejection Fraction Regardless of Diabetes Status
Favorite
3:30 PM – 5:00 PM
(1-284) Suicide-related Events Among the Use of Glucagon-like peptide-1 Receptor Agonists in a Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-293) Synvisc-One™ for the Treatment of Osteoarthritis of the Knee: Evaluation of the Non-formulary Request Process and Review of Appropriate Use
Favorite
3:30 PM – 5:00 PM
(1-265) Telehealth Expansion During the COVID-19 Pandemic: Veteran Access to Patient Aligned Care Team Clinical Pharmacist Practitioners
Favorite
3:30 PM – 5:00 PM
(1-006) Temporal Trends in Usage for Oral vs. Intravenous Antibiotics for Serious Infections in the Outpatient Setting in a Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-212) The Association of Pharmacogenomic Phenotype Variants in CYP2D6, CYP2C9, CYP2C19, and CYP3A5 with Polypharmacy in Veterans
Favorite
3:30 PM – 5:00 PM
(1-275) The Development of Standardized Antidote and Reversal Agent Protocols and Order Sets
Favorite
3:30 PM – 5:00 PM
(1-081) The Effect of Dolutegravir vs. Bictegravir on Metformin in Diabetes Management
Favorite
3:30 PM – 5:00 PM
(1-263) The Effectiveness of Clinical Pharmacy Practitioner Management of Glycemic Control Among Outpatient Veterans with Type 2 Diabetes
Favorite
3:30 PM – 5:00 PM
(1-187) The Effects of Real-Time and Intermittently Scanned Continuous Glucose Monitoring on Glycemic Control in Veterans with Type Two Diabetes
Favorite
3:30 PM – 5:00 PM
(1-257) The Impact of an Educational Intervention Provided by Clinical Pharmacists to Veterans with Opioid Used Disorder (OUD) to Promote Enrolment in Substance Use Disorders Clinics
Favorite
3:30 PM – 5:00 PM
(1-049) The Use of Opioids and Non-opioid Analgesics in Kidney and Liver Transplants Recipients During the Perioperative and Postoperative Period
Favorite
3:30 PM – 5:00 PM
(1-003) Therapeutic Novelties in Migraine: Anti-calcitonin Gene-related Peptide Monoclonal Antibodies
Favorite
3:30 PM – 5:00 PM
(1-072) Timing of Antibiotic Initiation for Suspected Sepsis in a Veterans Affairs Community Living Center
Favorite
3:30 PM – 5:00 PM
(1-141) Tolerability of Empagliflozin in Older Adults
Favorite
3:30 PM – 5:00 PM
(1-303) Tolerability of Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction Patients Receiving Hydralazine and Isosorbide Dinitrate
Favorite
3:30 PM – 5:00 PM
(1-343) Transitioning an Outpatient Dialysis Clinic from Patient-specific Orders to Floor Stock
Favorite
3:30 PM – 5:00 PM
(1-038) Transitions of Care in Patients with Diabetes and Peripheral Vascular Disease
Favorite
3:30 PM – 5:00 PM
(1-314) Treating Retinopathy Screenings as a Vital Sign for Diabetics at the Pharmacy
Favorite
3:30 PM – 5:00 PM
(1-110) Treatment Patterns, Effectiveness, and Safety of Insulin Glargine Originator versus a Biosimilar Within the Veterans Health Administration
Favorite
3:30 PM – 5:00 PM
(1-004) Trends and Adverse Outcomes in Central Nervous System Prescriptions for Pain Before and After an Opioid Safety Initiative in the Veterans Health Administration
Favorite
3:30 PM – 5:00 PM
(1-338) Unfractionated Heparin Monitoring: Transitioning from aPTT to anti-Xa at the Cheyenne VA Health Care System
Favorite
3:30 PM – 5:00 PM
(1-290) Uric Acid Monitoring Practices in Patients with Gout
Favorite
3:30 PM – 5:00 PM
(1-001) Use of Eculizumab in a Tertiary Level Hospital
Favorite
3:30 PM – 5:00 PM
(1-002) Use of Omalizumab in Chemotherapy Desensitization Protocols
Favorite
3:30 PM – 5:00 PM
(1-169) Utility of an Electronic Clinical Surveillance Tool for Monitoring of Select Durations of Antibiotic Therapies
Favorite
3:30 PM – 5:00 PM
(1-148) Utilization of a Veterans Health Administration Home Telehealth Service in Heart Failure Guideline-Directed Medical Therapy Initiation and Optimization
Favorite
3:30 PM – 5:00 PM
(1-036) Utilization of Concomitant Anti-Inflammatory Prophylaxis with Urate-Lowering Therapy Initiation in a Veteran Population
Favorite
3:30 PM – 5:00 PM
(1-057) Utilization of Esketamine in Patients with Treatment Resistant Depression at a VA Healthcare System
Favorite
3:30 PM – 5:00 PM
(1-221) Utilization of Lurasidone for the Treatment of Major Depressive Disorder vs. Bipolar Depression in a Veterans Affairs Outpatient Mental Health Clinic
Favorite
3:30 PM – 5:00 PM
(1-235) Utilization of Penicillin Skin Testing to Decrease Broad Spectrum Antibiotic Prescribing in the Inpatient Setting
Favorite
3:30 PM – 5:00 PM
(1-135) Utilizing Patient Aligned Care Team (PACT) Pharmacist Intervention to Renally Dose Type 2 Diabetes Medications: A Quality Improvement Project
Favorite
3:30 PM – 5:00 PM
(1-255) Validation of Vancomycin Dosing Tool and the Impact of Area Under the Curve Targeted Dosing on Clinical Outcomes
Favorite
3:30 PM – 5:00 PM
(1-147) Veteran Experiences with Hybrid Closed Loop (HCL) Insulin Pumps for Type 1 Diabetes (T1D) Management
Favorite
3:30 PM – 5:00 PM
(1-258) Weight Management Medications for Chronic Use Medication Use Evaluation
Favorite
Back to Top
